VitalSigns
Med-Sci Matters by Dr. Lizzie

Med-Sci Matters by Dr. Lizzie

In this week’s edition of Med-Sci Matters, we discuss the FDA’s green light for CAR-T therapy, how house dust could be contributing to weight gain, how smartphones are providing insights into global activity levels and new data showing that artificial... Read More

July 19, 2017 0 Comments
The Week That Was: Crises in Communications

April 10, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

Domestic issues decidedly took a back seat to international affairs last week, as evidenced by a shift in media coverage. A few health news items did rise to the fore: The American Society of Clinical Oncology (ASCO) became the first...

Dr. Dave’s Med-Sci Matters

Written by

Gene therapy success! For the first time, gene therapy has successfully treated a common genetic disorder:  sickle cell disease (SCD), which affects 100,000 people in the United States and millions globally. People with SCD have abnormal hemoglobin due to a...

Expanded Access Programs Require Compassionate Communications to Keep Your Reputation Intact

April 3, 2017

0 Comments

Categories: Advocacy, Communications, Healthcare, Patient Communications

Expanded Access Programs Require Compassionate Communications to Keep Your Reputation Intact

Written by

No company wants to be seen as uncaring, least of all in the healthcare space. Clients I’ve supported in this sector are often passionate about their mission to bring new and better treatment options to patients. But companies’ intentions may...

The Week That Was: Crises in Communications

April 3, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

Although this weekend marks April Fools’ Day, our stories this week are no joke. The potent combination of Twitter and spandex nearly grounded United Airlines. Senate Dems jumped back into the healthcare debate with new legislation related to drug pricing,...

The Week That Was: Crises in Communications

March 27, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

For once, CSPAN was enthralling in the lead up to the choice Speaker Paul Ryan made last Friday to pull the American Health Care Act after failing to secure enough support from his party. The AHCA was the “repeal and...

The Week That Was: Crises in Communications

March 20, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

As Madness grips the nation’s attention for three weeks, changes to our nation’s healthcare system March on. Bernie Sanders thinks broadcasters are betting on their favorites, while some new pricing plans want to bust payer brackets and replace them with...

The Week That Was: Crises in Communications

March 15, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

March certainly came in like a lion, between the actual snowstorms and flurry of legislative and regulatory activity in Washington. While much of the week’s coverage focused on political posturing around the GOP’s ACA replacement bill, President Trump met with...

The Week That Was: Crises in Communications

March 6, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

Storylines last week focused on drama, mystery, and intrigue. Our top case revolves around the case of the missing healthcare bill. Following President Trump’s address that focused heavily on overhauling healthcare, the GOP promised to unveil its replacement to the...

The Week That Was: Crises in Communications

February 27, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

As Hollywood celebrated its biggest night of the year, The Week That Was recognizes some outstanding dramas in healthcare. PBMs, the longtime Hidden Figures of the pharmaceutical supply chain, get some unwanted spotlight for alleged clawback practices. A former Bush...

Dr. Dave’s Med-Sci Matters

February 20, 2017

0 Comments

Categories: Global Healthcare, Health and Wellness, Healthcare

Dr. Dave’s Med-Sci Matters

Written by

Genetically altering humans? Maybe we Khan! While advances in gene therapy research continue to accelerate, an enduring redline has been the germline – no tinkering with the DNA of a human embryo, egg or sperm. Doing so would mean not...